{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:42:01Z","timestamp":1787164921710,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.autrev.2026.104086","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:56:25Z","timestamp":1779206185000},"page":"104086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enteropathy in STAT3 GOF syndrome: Insights into the role of the JAK-STAT pathway"],"prefix":"10.1016","volume":"25","author":[{"given":"C.","family":"Caranfil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Crepaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marzollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Palo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dei Tos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zingone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104086_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/j.gastro.2020.08.061","article-title":"AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104086_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MEG.0000000000001340","article-title":"Overview in the clinical management of patients with seronegative villous atrophy","volume":"31","author":"Schiepatti","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0015","doi-asserted-by":"crossref","first-page":"102609","DOI":"10.1016\/j.jaut.2021.102609","article-title":"Immune-mediated enteropathies: from bench to bedside","volume":"118","author":"van Wanrooij","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104086_bb0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.14309\/ajg.0000000000000575","article-title":"Management of small bowel villous atrophy in patients seronegative for celiac disease","volume":"115","author":"Jansson-Knodell","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and Meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0030","first-page":"23","article-title":"Patient and community health global burden in a world with more celiac disease","volume":"167","author":"Gatti","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104086_bb0400","doi-asserted-by":"crossref","first-page":"e70195","DOI":"10.1002\/ueg2.70195","article-title":"European Society for the Study of Coeliac Disease (ESsCD) 2025 updated guidelines on the diagnosis and management of Coeliac Disease in adults. Part 2: Management, follow-up, and complex disease courses [Internet]","volume":"14","author":"Al-Toma","year":"2026","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.autrev.2026.104086_bb0045","first-page":"22","article-title":"Digestion and absorption","author":"McQuilken","year":"2021","journal-title":"Anaesth Intens Care Med"},{"key":"10.1016\/j.autrev.2026.104086_bb0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.dld.2022.06.023","article-title":"Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis","volume":"54","author":"Zingone","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2026.104086_bb0275","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1136\/gutjnl-2021-326645","article-title":"Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus","volume":"71","author":"Schiepatti","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104086_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241752","article-title":"Chronic enteropathy-related malabsorption syndrome in an adult with common variable immunodeficiency and symptomatic norovirus infection of the gut","volume":"14","author":"Jain","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2026.104086_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2005.03.063","article-title":"Long-term parenteral nutrition in Pediatric autoimmune enteropathies","volume":"37","author":"Gambarara","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2026.104086_bb0085","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.14309\/ajg.0000000000003331","article-title":"Long-term prognosis of nonceliac enteropathies and a score to identify patients with poor outcomes: a 30-year Multicenter longitudinal study","volume":"120","author":"Schiepatti","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-024-00962-9","article-title":"Cellular and molecular basis of proximal small intestine disorders","volume":"2","author":"Bildstein","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104086_bb0110","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104086_bb0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104086_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2026.104086_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8933","article-title":"Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation","volume":"376","author":"Glassman","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104086_bb0130","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104086_bb0135","article-title":"The JAK-STAT pathway: from structural biology to cytokine engineering","volume":"221","author":"Lv","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.autrev.2026.104086_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0145","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41385-021-00398-3","article-title":"Intestinal immunoregulation: lessons from human mendelian diseases","volume":"14","author":"Charbit-Henrion","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1766513","article-title":"Immune cell dynamics and mechanisms of epithelial injury in celiac disease","volume":"17","author":"Marafini","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 Signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104086_bb0170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","article-title":"IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease","volume":"578","author":"Abadie","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104086_bb0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2013.12.023","article-title":"Interleukin 15 and CD4+ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen","volume":"146","author":"Korneychuk","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104086_bb0180","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mi.2010.36","article-title":"HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22","volume":"3","author":"Bodd","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0185","first-page":"551","article-title":"Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease","volume":"115","author":"Nilsen","year":"1998"},{"key":"10.1016\/j.autrev.2026.104086_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2024.03.042","article-title":"New insights on genes, gluten, and immunopathogenesis of celiac disease","volume":"167","author":"Abadie","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104086_bb0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/biom16020219","article-title":"The Interleukin-7 receptor Signaling pathway and its perturbation in immunodeficiency, autoimmune disease and lymphoid malignancy","volume":"16","author":"Ward","year":"2026","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.autrev.2026.104086_bb0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/ACI.0000000000001139","article-title":"STAT wars: how STATopathies sabotage innate immunity","volume":"26","author":"Bloomfield","year":"2026","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0205","doi-asserted-by":"crossref","first-page":"770077","DOI":"10.3389\/fped.2022.770077","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2026.104086_bb0210","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0002-9440(10)64319-2","article-title":"Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions","volume":"162","author":"Mazzarella","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2026.104086_bb0215","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104086_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110979","article-title":"Activating mutations of STAT3: impact on human growth","volume":"518","author":"Guti\u00e9rrez","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.autrev.2026.104086_bb0225","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.autrev.2026.104086_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400348","article-title":"JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review","volume":"15","author":"Atschekzei","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0250","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000387","article-title":"Adult-onset autoimmune enteropathy in an European tertiary referral center","volume":"12","author":"Van Wanrooij","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(97)01042-8","article-title":"Autoimmune enteropathy and villous atrophy in adults","volume":"350","author":"Corazza","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104086_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000630","article-title":"Enteropathies with villous atrophy but negative coeliac serology in adults: current issues","volume":"8","author":"Schiepatti","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11894-012-0276-2","article-title":"Autoimmune enteropathy: a review and update of clinical management","volume":"14","author":"Gentile","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.autrev.2026.104086_bb0270","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10620-020-06540-8","article-title":"A review of autoimmune enteropathy and its associated syndromes","volume":"65","author":"Chen","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2026.104086_bb0280","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"{a figure is presented}adult autoimmune enteropathy: Mayo Clinic Rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0285","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","article-title":"IPEX syndrome from diagnosis to cure, learning along the way","volume":"153","author":"Bacchetta","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0290","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2026.104086_bb0295","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2025.07.024","article-title":"Mechanistic and therapeutic advances in immune-mediated gastrointestinal disorders","volume":"156","author":"Garabatos","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0300","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cgh.2022.07.030","article-title":"Genetic diagnosis guides treatment of autoimmune enteropathy","volume":"21","author":"Charbit-Henrion","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-025-03731-2","article-title":"Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy","volume":"20","author":"Li","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2026.104086_bb0310","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000520","article-title":"Successful treatment of refractory autoimmune enteropathy with Ustekinumab","volume":"8","author":"Scheid","year":"2021","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.autrev.2026.104086_bb0315","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10620-005-2666-x","article-title":"Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab","volume":"50","author":"Elwing","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2026.104086_bb0320","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.14309\/02075970-201805120-00008","article-title":"New treatment option for autoimmune enteropathy: a rare case of intractable Diarrhea treated with vedolizumab","volume":"5","author":"Robbins","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.autrev.2026.104086_bb0325","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2018.11.065","article-title":"Efficacy of Ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation","volume":"156","author":"Parlato","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104086_bb0330","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/ibd\/izaf002","article-title":"Upadacitinib in autoimmune enteropathy - a case report","volume":"31","author":"Chin","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2026.104086_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical Spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-025-01920-z","article-title":"CVID enteropathy is difficult to treat and shows a heterogeneous histopathology","volume":"45","author":"Juliana","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0345","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","article-title":"Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation","volume":"586","author":"Kobbe","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.autrev.2026.104086_bb0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","article-title":"Whole-genome sequencing of a sporadic primary immunodeficiency cohort","volume":"583","author":"Thaventhiran","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104086_bb0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clim.2017.11.007","article-title":"A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)","volume":"187","author":"Russell","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0360","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10875-022-01379-2","article-title":"Interferon-driven immune dysregulation in common variable immunodeficiency\u2013associated villous atrophy and norovirus infection","volume":"43","author":"Strohmeier","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0365","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ejh.14265","article-title":"Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: a study of 12 cases","volume":"113","author":"Gueuning","year":"2024","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2026.104086_bb0370","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-023-01569-6","article-title":"JAK inhibition with Baricitinib for severe CVID-related enteropathy: a case report","volume":"43","author":"Abdelmoumen","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0375","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","article-title":"Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II","volume":"45","author":"Soderquist","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2026.104086_bb0380","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104086_bb0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2026.104086_bb0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104086_bb0395","doi-asserted-by":"crossref","first-page":"eadp6812","DOI":"10.1126\/scitranslmed.adp6812","article-title":"Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease","volume":"17","author":"Singh","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104086_bb0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.autrev.2026.104086_bb0405","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2007.01380.x","article-title":"Budesonide in the treatment of refractory celiac disease","volume":"102","author":"Brar","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0410","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s10620-024-08436-3","article-title":"Budesonide induces favourable histologic and symptomatic recovery in patients with non-responsive and refractory coeliac disease when given in an open capsule format","volume":"69","author":"Saitta","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2026.104086_bb0415","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a Janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104086_bb0420","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104086_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244692","article-title":"Successful novel use of tofacitinib for type ii refractory coeliac disease","volume":"15","author":"Grewal","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2026.104086_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101960","article-title":"Normalization of duodenal mucosa after treatment with Janus kinase (JAK) inhibitor in refractory celiac disease type 2","volume":"46","author":"Nandi","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104086_bb0435","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.cgh.2024.05.022","article-title":"Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study","volume":"22","author":"Dieckman","year":"2024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:42:33Z","timestamp":1785166953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722600100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S156899722600100X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104086","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteropathy in STAT3 GOF syndrome: Insights into the role of the JAK-STAT pathway","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104086"}}